ScholarIQanswers from OpenAlex

β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects

PaperCitations, authors & open-access status

β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects is a paper indexed in ScholarIQ from OpenAlex.

How many citations does β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects have?

ScholarIQcitation count

β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects has 144 citations in the OpenAlex counts ScholarIQ stores.

When was β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects published?

ScholarIQyear

β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects has 2019 year in the ScholarIQ index.

What is the open-access status of β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects?

ScholarIQoa status

β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects has hybrid oa status in the ScholarIQ index.

What is the DOI of β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects?

ScholarIQdoi

The DOI for β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects is on the source record.

What is the PMID of β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects?

ScholarIQpmid

The PMID for β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects is on the source record.

What is the OpenAlex record for β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects?

ScholarIQopenalex

The OpenAlex for β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial